Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Balzano

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
The British Journal of Surgery|January 19, 2016
Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgeryN Pecorelli, G Carrara, F De Cobelli, et al.
Arthritis and Rheumatism|February 1, 1995
Evaluation of bone turnover and bone mass during tapering estrogen therapy: a preliminary reportF P Cantatore, E Cicinelli, P Galantino, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coilS Sironi, F De Cobelli, A Zerbi, et al.
Allergy|September 12, 2001
Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthmaG Melillo, G Balzano, S Bianco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinomaM Reni, P Passoni, M G Panucci, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|April 1, 1997
Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patientsG Balzano, C Bassi, A Zerbi, et al.
Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.
American Journal of Clinical Oncology|April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapyM Reni, S Cereda, E Mazza, et al.
Genomics|January 7, 1998
Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomasI Biunno, V Appierto, M Cattaneo, et al.
Cancer Chemotherapy and Pharmacology|June 30, 2006
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinomaM Reni, S Cereda, E Bonetto, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
The British Journal of Surgery|January 19, 2016
Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgeryN Pecorelli, G Carrara, F De Cobelli, et al.
Arthritis and Rheumatism|February 1, 1995
Evaluation of bone turnover and bone mass during tapering estrogen therapy: a preliminary reportF P Cantatore, E Cicinelli, P Galantino, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coilS Sironi, F De Cobelli, A Zerbi, et al.
Allergy|September 12, 2001
Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthmaG Melillo, G Balzano, S Bianco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinomaM Reni, P Passoni, M G Panucci, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|April 1, 1997
Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patientsG Balzano, C Bassi, A Zerbi, et al.
Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.
American Journal of Clinical Oncology|April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapyM Reni, S Cereda, E Mazza, et al.
Genomics|January 7, 1998
Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomasI Biunno, V Appierto, M Cattaneo, et al.
Cancer Chemotherapy and Pharmacology|June 30, 2006
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinomaM Reni, S Cereda, E Bonetto, et al.
Pageof 8